Monday, June 10, 2019 8:45:39 AM
Hey Hunchback, that agreement with TGS is for consulting on oils, derivative products and branding not a US distribution. OGI paid TGS in shares for their services. TGS most likely was very influential on OGI's recent 15mm expenditure for their edibles facility. It's illegal to ship products into the US. The only company that was able to do this so far was Tilray, for some research study at one of the universities in California. They got some kinda special permission to do so.
https://www.organigram.ca/latest/exclusive-partnership-for-oils-extracts-and-edibles-announced/
ORGANIGRAM ENTERS EXCLUSIVE PARTNERSHIP FOR OILS, EXTRACTS AND EDIBLES
Moncton, New Brunswick, September 1, 2016 – OrganiGram Holdings Inc. (TSX-V: OGI, OTCQB:
OGRMF) (the “Company” or “OrganiGram”) is pleased to announce it has entered into an
exclusive product development and distribution agreement with TGS International, LLC (“TGS
International”). The agreement will provide for consulting services related to the development
and operation of a commercial scale cannabis extracts production and processing facility, as well
as the exclusive licensing in Canada of over 225 unique cannabis products.
TGS International is an affiliate of The Green Solution, LLC (“TGS”), a vertically-integrated
cannabis company which owns and operates over 300,000 square feet of state licensed and
regulated production, processing, and manufacturing facilities as well as 11 medicinal and/or
adult-use retail locations in the state of Colorado, with three additional locations set to open by
the end of 2016. TGS has commercially developed an extensive line of cannabis extract and
derivative products by using multiple extraction methodologies that are streamlined with
standardized operating procedures and supported through proprietary software and security
systems.
“TGS has distinguished itself as a leader in the Colorado medical and adult-use cannabis markets
in terms of their sales, product quality, and reliability. Their award winning proprietary brands,
The Green Solution™ and NectarBee™ have generated well over US$100MM in cumulative sales
through their affiliated Colorado operations, including over US$43MM in 2015 alone” says Denis
Arsenault, Chief Executive Officer of the Company.
“OrganiGram has worked tirelessly towards the development and communication of a clear
business development strategy for our company and our shareholders. Today’s announcement
represents the culmination of that process for our commercial extracts strategy. OrganiGram has
now raised the necessary capital, secured the required real estate, and has selected the ideal
strategic partner to position OrganiGram as a major force in the emerging oils and edibles
market,” says Arsenault.
Eric Speidell, Co-Chief Executive Officer of TGS states “TGS is very excited to enter the Canadian
market and to partner with one of the industry’s leading licensed producers. Over the past six
years, we have proactively invested significant resources into the standardization, quality, and
reliability of our processes and products. We are very proud of the success we have achieved to
date in Colorado. Our brands and leadership have been recognized across the United States, with
TGS franchises already established in multiple states. With this transaction, we are eager to
embark on our international expansion with OrganiGram.”
Pursuant to the agreement between the Company and TGS, and subject to the approval of the
TSX Venture Exchange (the "TSXV") and other regulatory approval as may be required, the
Company shall issue 437,957 common shares to TGS at a price of $1.37 per share, payable after
certain calendar and operational milestones, and will provide additional cash consideration to
TGS, by way of a royalty, during the term of the Agreement. Additionally, TGS shall be issued
stock options in accordance with a 36-month vesting schedule.
For further information:
OrganiGram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986
www.organigram.ca
https://www.organigram.ca/latest/exclusive-partnership-for-oils-extracts-and-edibles-announced/
ORGANIGRAM ENTERS EXCLUSIVE PARTNERSHIP FOR OILS, EXTRACTS AND EDIBLES
Moncton, New Brunswick, September 1, 2016 – OrganiGram Holdings Inc. (TSX-V: OGI, OTCQB:
OGRMF) (the “Company” or “OrganiGram”) is pleased to announce it has entered into an
exclusive product development and distribution agreement with TGS International, LLC (“TGS
International”). The agreement will provide for consulting services related to the development
and operation of a commercial scale cannabis extracts production and processing facility, as well
as the exclusive licensing in Canada of over 225 unique cannabis products.
TGS International is an affiliate of The Green Solution, LLC (“TGS”), a vertically-integrated
cannabis company which owns and operates over 300,000 square feet of state licensed and
regulated production, processing, and manufacturing facilities as well as 11 medicinal and/or
adult-use retail locations in the state of Colorado, with three additional locations set to open by
the end of 2016. TGS has commercially developed an extensive line of cannabis extract and
derivative products by using multiple extraction methodologies that are streamlined with
standardized operating procedures and supported through proprietary software and security
systems.
“TGS has distinguished itself as a leader in the Colorado medical and adult-use cannabis markets
in terms of their sales, product quality, and reliability. Their award winning proprietary brands,
The Green Solution™ and NectarBee™ have generated well over US$100MM in cumulative sales
through their affiliated Colorado operations, including over US$43MM in 2015 alone” says Denis
Arsenault, Chief Executive Officer of the Company.
“OrganiGram has worked tirelessly towards the development and communication of a clear
business development strategy for our company and our shareholders. Today’s announcement
represents the culmination of that process for our commercial extracts strategy. OrganiGram has
now raised the necessary capital, secured the required real estate, and has selected the ideal
strategic partner to position OrganiGram as a major force in the emerging oils and edibles
market,” says Arsenault.
Eric Speidell, Co-Chief Executive Officer of TGS states “TGS is very excited to enter the Canadian
market and to partner with one of the industry’s leading licensed producers. Over the past six
years, we have proactively invested significant resources into the standardization, quality, and
reliability of our processes and products. We are very proud of the success we have achieved to
date in Colorado. Our brands and leadership have been recognized across the United States, with
TGS franchises already established in multiple states. With this transaction, we are eager to
embark on our international expansion with OrganiGram.”
Pursuant to the agreement between the Company and TGS, and subject to the approval of the
TSX Venture Exchange (the "TSXV") and other regulatory approval as may be required, the
Company shall issue 437,957 common shares to TGS at a price of $1.37 per share, payable after
certain calendar and operational milestones, and will provide additional cash consideration to
TGS, by way of a royalty, during the term of the Agreement. Additionally, TGS shall be issued
stock options in accordance with a 36-month vesting schedule.
For further information:
OrganiGram Holdings Inc.
Giselle Doiron
Director of Investor and Media Relations
(506) 801-8986
www.organigram.ca
Recent OGI News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/17/2026 12:33:10 PM
- Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities • Business Wire • 04/15/2026 04:03:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/31/2026 01:55:58 AM
- Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting • Business Wire • 03/31/2026 12:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/23/2026 02:10:09 PM
- Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH • Business Wire • 03/23/2026 10:00:00 AM
- Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting • Business Wire • 03/10/2026 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/09/2026 09:14:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 05:27:39 PM
- Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity • Business Wire • 03/05/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/03/2026 05:23:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/24/2026 04:18:03 PM
- Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia • Business Wire • 02/24/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2026 09:58:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/19/2026 07:21:54 PM
- Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group • Business Wire • 02/19/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/18/2026 03:40:13 PM
- Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company • Business Wire • 02/18/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/10/2026 12:41:44 PM
- Organigram Reports First Quarter Fiscal 2026 Results • Business Wire • 02/10/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/03/2026 04:10:05 PM
- Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 • Business Wire • 02/03/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/31/2025 02:49:11 PM
- Organigram Extends Innovation Investment with Phylos • Business Wire • 12/31/2025 11:00:00 AM
